Daniel R. Chard

Chairman & Chief Executive OfficeratMedifast· In proxies 2021–2025

Pay in FY20250% from the year before

Daniel R. Chard was paid $5.6M in FY2025 (Dec), the same as the year before.

PayNo stock prices for these years

Pay is from the Summary Compensation Table of each Medifast proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

MED
MedifastPublic company · 5 yr
- Chairman & Chief Executive Officer2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

Pay
Medifast CEO pay fell 20% to $5.6M in FY2024 (Dec).
DEF 14AApr 29, 2025
Pay
Medifast CEO pay rose 18% to $7.0M in FY2023 (Dec).
DEF 14AApr 26, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?